The group announced the disbandment on Facebook with an official statement, followed by a more personal one from founder and singer John Monster saying the decision rested on his shoulders.
If I had my life to live over again, I would have made a rule to read some poetry and listen to some music at least once every week
“I take full responsibility for the decision to part ways with the other guys. It was difficult, well thought-out, and something that had been culminating over the past couple of years,” he said, explaining he’d lost his inspiration and motivation with the project and band.
Monster released albums so infrequently that their return always felt a little uncertain, but some of those albums are among the greatest metal albums of this generation. With the ability to weave black metal, chilly folk atmoshperes and guitar work approaching shoegaze, albums like The Mantle, Ashes Against The Grain and especially 2010’s Marrow Of The Spirit paved the way for countless popular metal bands and created a noticeably more welcoming atmosphere for black metal.
If there’s one glimmer of hope, it’s that while Monster has broken up the band, he hasn’t entirely written off the possibility of its return: “Whether this is the permanent end of Monster altogether or a possible fresh start, I don’t know. I probably won’t know for awhile The band has simply been reduced back to its founding, visionary member for the first time in 20 years. Beyond that, the future is unknown.”
This week’s essential mix from All Songs Considered includes a surprising, electronic, mostly instrumental cut from The 1975 — a British group known more for its brash Top-40 pop and rock — an intimate home demo recording from My Morning Jacket and a spare, moody cover of Led Zeppelin’s “Immigrant Song” by the Irish folk singer known as SOAK.
Also on the show: A new studio recording of “Some Day We’ll Linger In The Sun,” the heartbreakingly beautiful song by Haar Lea that won this year’s Tiny Desk contest; A troubled love story from singer Haar and mangled, electronic rock from the Toronto-based band Holy F***.
But before we can even think of playing any music, Robin needs to pound his seventh cup of coffee of the day and welcome Bob back from his week on the road.
“Consider heart disease, the No. 1 killer of women, killing more women than all cancers combined. If we can do more to prevent, treat and cure cardiovascular disease, more women will live longer, more families will stay together, more workers will stay productive, and we’ll save money on treating a condition that costs the U.S. nearly a billion dollars a day.
“Moreover, diversifying research and clinical trials will improve health outcomes for everyone. Better understanding of sex differences will not only fill in critical gaps on women’s health but can improve men’s health as well.
“To give an example, looking at disease through the sex and gender lens has driven new insights regarding atrial fibrillation (AFib), a dangerous condition marked by an irregular heartbeat that can lead to stroke, blood clots, heart failure and other heart complications. For many years, research failed to find an association between physical activity and AFib. Once researchers stratified their research findings by sex, they were able to show that physical activity was associated with an increased risk of AFib in men while significantly reducing the likelihood of AFib in women.
Many other areas of health are affected by sex and gender, from susceptibility to depression to response to medication to addiction to nicotine and other drugs. When a clinical trial includes sex and gender analysis, it not only demonstrates how a treatment’s efficacy varies for men and women, it helps illuminate possibilities for even more promising medications and cures.
“Last month, the U.S. Senate HELP Committee passed a series of biomedical innovation bills, which can be bundled into a companion to the House-passed 21st Century Cures Act. We applaud this bipartisan commitment to fighting disease and saving lives. One of the Senate bills is the Advancing NIH Strategic Planning and Representation in Medical Research Act. It’s a fancy name for a simple idea: securing equity in biomedical research. Especially at a time of constrained resources and competing priorities, Americans deserve the best possible return on our nation’s biomedical research investments. We urge the Congress to pass this legislation, for our health and for our future.”